Morgan Stanley raised its price objective for Ionis Pharmaceuticals stock, which trades on the Nasdaq exchange.
1 report, 1 independent
Updated Jul 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley raised its price objective for Ionis Pharmaceuticals stock, which trades on the Nasdaq exchange.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Ionis Pharmaceuticals
American pharmaceutical company
Nothing else this week.
-
Morgan Stanley
U.S. investment bank
Related events
- Morgan Stanley was involved in market activity on the electronic stock exchange, with filings received regarding this activity.
- Morgan Stanley and Carlyle Group released research reports and price targets for a company whose stock trades on the Nasdaq platform.
- Morgan Stanley boosted its price objective on Visteon shares.
- Morgan Stanley raised its price objective for Williams Companies.
- Morgan Stanley adjusted its price objective for Lincoln Electric, and DA Davidson assumed coverage on the company.